Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database

H. Byakwaga, K. Petoumenos, J. Ananworanich, F. Zhang, M. A. Boyd, T. Sirisanthana, P. C.K. Li, C. Lee, C. V. Mean, V. Saphonn, S. F.S. Omar, S. Pujari, P. Phanuphak, P. L. Lim, N. Kumarasamy, Y. M.A. Chen, T. P. Merati, S. Sungkanuparph, R. Ditangco, S. OkaG. Tau, J. Zhou, M. G. Law, S. Emery

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The majority of HIV-infected patients in developing countries commences combination antiretroviral therapy (cART) with advanced disease. We examined predictors of disease progression in patients initiating cART with CD4 count ≤200 cells/mm3 in the TREAT Asia HIV Observational Database. The main outcome measure was progression to either an AIDS-defining illness or death occurring 6 months after initiation of cART. We used survival analysis methods. A total of 1255 patients contributed 2696 person years of follow-up; 73 were diagnosed with AIDS and 9 died. The rate of progression to the combined end point was 3.0 per 100 person years. The factors significantly associated with a higher risk of disease progression were Indian ethnicity, infection through intravenous drug use, lower CD4 count, and hemoglobin ≤130 g/dL at 6 months. In conclusion, measurements of CD4 count and hemoglobin at month 6 may be useful for early identification of disease progression in resource-limited settings.

Original languageEnglish
Pages (from-to)270-277
Number of pages8
JournalJournal of the International Association of Providers of AIDS Care
Volume12
Issue number4
DOIs
Publication statusPublished - Jul 1 2013
Externally publishedYes

Fingerprint

CD4 Lymphocyte Count
Disease Progression
HIV-1
HIV
Databases
Acquired Immunodeficiency Syndrome
Hemoglobins
Survival Analysis
Developing Countries
Therapeutics
Outcome Assessment (Health Care)
Infection
Pharmaceutical Preparations

Keywords

  • antiretroviral therapy
  • disease progression
  • HIV
  • resource-limited settings

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Cite this

Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region : Results from the TREAT Asia HIV Observational Database. / Byakwaga, H.; Petoumenos, K.; Ananworanich, J.; Zhang, F.; Boyd, M. A.; Sirisanthana, T.; Li, P. C.K.; Lee, C.; Mean, C. V.; Saphonn, V.; Omar, S. F.S.; Pujari, S.; Phanuphak, P.; Lim, P. L.; Kumarasamy, N.; Chen, Y. M.A.; Merati, T. P.; Sungkanuparph, S.; Ditangco, R.; Oka, S.; Tau, G.; Zhou, J.; Law, M. G.; Emery, S.

In: Journal of the International Association of Providers of AIDS Care, Vol. 12, No. 4, 01.07.2013, p. 270-277.

Research output: Contribution to journalArticle

Byakwaga, H, Petoumenos, K, Ananworanich, J, Zhang, F, Boyd, MA, Sirisanthana, T, Li, PCK, Lee, C, Mean, CV, Saphonn, V, Omar, SFS, Pujari, S, Phanuphak, P, Lim, PL, Kumarasamy, N, Chen, YMA, Merati, TP, Sungkanuparph, S, Ditangco, R, Oka, S, Tau, G, Zhou, J, Law, MG & Emery, S 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, vol. 12, no. 4, pp. 270-277. https://doi.org/10.1177/1545109712469684
Byakwaga, H. ; Petoumenos, K. ; Ananworanich, J. ; Zhang, F. ; Boyd, M. A. ; Sirisanthana, T. ; Li, P. C.K. ; Lee, C. ; Mean, C. V. ; Saphonn, V. ; Omar, S. F.S. ; Pujari, S. ; Phanuphak, P. ; Lim, P. L. ; Kumarasamy, N. ; Chen, Y. M.A. ; Merati, T. P. ; Sungkanuparph, S. ; Ditangco, R. ; Oka, S. ; Tau, G. ; Zhou, J. ; Law, M. G. ; Emery, S. / Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region : Results from the TREAT Asia HIV Observational Database. In: Journal of the International Association of Providers of AIDS Care. 2013 ; Vol. 12, No. 4. pp. 270-277.
@article{ac26f0e4a82840549919539707768f9a,
title = "Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database",
abstract = "The majority of HIV-infected patients in developing countries commences combination antiretroviral therapy (cART) with advanced disease. We examined predictors of disease progression in patients initiating cART with CD4 count ≤200 cells/mm3 in the TREAT Asia HIV Observational Database. The main outcome measure was progression to either an AIDS-defining illness or death occurring 6 months after initiation of cART. We used survival analysis methods. A total of 1255 patients contributed 2696 person years of follow-up; 73 were diagnosed with AIDS and 9 died. The rate of progression to the combined end point was 3.0 per 100 person years. The factors significantly associated with a higher risk of disease progression were Indian ethnicity, infection through intravenous drug use, lower CD4 count, and hemoglobin ≤130 g/dL at 6 months. In conclusion, measurements of CD4 count and hemoglobin at month 6 may be useful for early identification of disease progression in resource-limited settings.",
keywords = "antiretroviral therapy, disease progression, HIV, resource-limited settings",
author = "H. Byakwaga and K. Petoumenos and J. Ananworanich and F. Zhang and Boyd, {M. A.} and T. Sirisanthana and Li, {P. C.K.} and C. Lee and Mean, {C. V.} and V. Saphonn and Omar, {S. F.S.} and S. Pujari and P. Phanuphak and Lim, {P. L.} and N. Kumarasamy and Chen, {Y. M.A.} and Merati, {T. P.} and S. Sungkanuparph and R. Ditangco and S. Oka and G. Tau and J. Zhou and Law, {M. G.} and S. Emery",
year = "2013",
month = "7",
day = "1",
doi = "10.1177/1545109712469684",
language = "English",
volume = "12",
pages = "270--277",
journal = "Journal of the International Association of Providers of AIDS Care",
issn = "2325-9574",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region

T2 - Results from the TREAT Asia HIV Observational Database

AU - Byakwaga, H.

AU - Petoumenos, K.

AU - Ananworanich, J.

AU - Zhang, F.

AU - Boyd, M. A.

AU - Sirisanthana, T.

AU - Li, P. C.K.

AU - Lee, C.

AU - Mean, C. V.

AU - Saphonn, V.

AU - Omar, S. F.S.

AU - Pujari, S.

AU - Phanuphak, P.

AU - Lim, P. L.

AU - Kumarasamy, N.

AU - Chen, Y. M.A.

AU - Merati, T. P.

AU - Sungkanuparph, S.

AU - Ditangco, R.

AU - Oka, S.

AU - Tau, G.

AU - Zhou, J.

AU - Law, M. G.

AU - Emery, S.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The majority of HIV-infected patients in developing countries commences combination antiretroviral therapy (cART) with advanced disease. We examined predictors of disease progression in patients initiating cART with CD4 count ≤200 cells/mm3 in the TREAT Asia HIV Observational Database. The main outcome measure was progression to either an AIDS-defining illness or death occurring 6 months after initiation of cART. We used survival analysis methods. A total of 1255 patients contributed 2696 person years of follow-up; 73 were diagnosed with AIDS and 9 died. The rate of progression to the combined end point was 3.0 per 100 person years. The factors significantly associated with a higher risk of disease progression were Indian ethnicity, infection through intravenous drug use, lower CD4 count, and hemoglobin ≤130 g/dL at 6 months. In conclusion, measurements of CD4 count and hemoglobin at month 6 may be useful for early identification of disease progression in resource-limited settings.

AB - The majority of HIV-infected patients in developing countries commences combination antiretroviral therapy (cART) with advanced disease. We examined predictors of disease progression in patients initiating cART with CD4 count ≤200 cells/mm3 in the TREAT Asia HIV Observational Database. The main outcome measure was progression to either an AIDS-defining illness or death occurring 6 months after initiation of cART. We used survival analysis methods. A total of 1255 patients contributed 2696 person years of follow-up; 73 were diagnosed with AIDS and 9 died. The rate of progression to the combined end point was 3.0 per 100 person years. The factors significantly associated with a higher risk of disease progression were Indian ethnicity, infection through intravenous drug use, lower CD4 count, and hemoglobin ≤130 g/dL at 6 months. In conclusion, measurements of CD4 count and hemoglobin at month 6 may be useful for early identification of disease progression in resource-limited settings.

KW - antiretroviral therapy

KW - disease progression

KW - HIV

KW - resource-limited settings

UR - http://www.scopus.com/inward/record.url?scp=84880437582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880437582&partnerID=8YFLogxK

U2 - 10.1177/1545109712469684

DO - 10.1177/1545109712469684

M3 - Article

C2 - 23422741

AN - SCOPUS:84880437582

VL - 12

SP - 270

EP - 277

JO - Journal of the International Association of Providers of AIDS Care

JF - Journal of the International Association of Providers of AIDS Care

SN - 2325-9574

IS - 4

ER -